David Kryza

The biodistribution of gold nanoparticles designed for renal clearance

Christophe Alric, Imen Miladi, David Kryza et al. · Nanoscale · 2013 · 144 citations

Pharmacy, Biomedical Engineering, Nuclear Medicine +17

Biodistribution Study of Nanometric Hybrid Gadolinium Oxide Particles as a Multimodal SPECT/MR/Optical Imaging and Theragnostic Agent

David Kryza, Jacqueline Taleb, M. Janier et al. · Bioconjugate Chemistry · 2011 · 102 citations

Pharmacy, Nuclear Medicine, Pharmacokinetics +17

Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma

Imen Miladi, Marie‐Thérèse Aloy, Emma Armandy et al. · Nanomedicine Nanotechnology Biology and Medicine · 2014 · 76 citations

Medicine, Oncology, Radiation Oncology +12

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients

Anne‐Laure Giraudet, Philippe A. Cassier, Chicaco Iwao-Fukukawa et al. · BMC Cancer · 2018 · 65 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Fully automated [18F]fluorocholine synthesis in the TracerLab MXFDG Coincidence synthesizer

David Kryza, Vincent Tadino, Maria Azzurra Filannino et al. · Nuclear Medicine and Biology · 2008 · 51 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5